Relative Expression Analysis for Molecular Cancer Diagnosis and Prognosis
Open Access
- 1 April 2010
- journal article
- research article
- Published by SAGE Publications in Technology in Cancer Research & Treatment
- Vol. 9 (2) , 149-159
Abstract
The enormous amount of biomolecule measurement data generated from high-throughput technologies has brought an increased need for computational tools in biological analyses. Such tools can enhance our understanding of human health and genetic diseases, such as cancer, by accurately classifying phenotypes, detecting the presence of disease, discriminating among cancer sub-types, predicting clinical outcomes, and characterizing disease progression. In the case of gene expression microarray data, standard statistical learning methods have been used to identify classifiers that can accurately distinguish disease phenotypes. However, these mathematical prediction rules are often highly complex, and they lack the convenience and simplicity desired for extracting underlying biological meaning or transitioning into the clinic. In this review, we survey a powerful collection of computational methods for analyzing transcriptomic microarray data that address these limitations. Relative Expression Analysis (RXA) is based only on the relative orderings among the expressions of a small number of genes. Specifically, we provide a description of the first and simplest example of RXA, the k-TSP classifier, which is based on k pairs of genes; the case k = 1 is the TSP classifier. Given their simplicity and ease of biological interpretation, as well as their invariance to data normalization and parameter-fitting, these classifiers have been widely applied in aiding molecular diagnostics in a broad range of human cancers. We review several studies which demonstrate accurate classification of disease phenotypes (e.g., cancer vs. normal), cancer subclasses (e.g., AML vs. ALL, GIST vs. LMS), disease outcomes (e.g., metastasis, survival), and diverse human pathologies assayed through blood-borne leukocytes. The studies presented demonstrate that RXA—specifically the TSP and k-TSP classifiers—is a promising new class of computational methods for analyzing high-throughput data, and has the potential to significantly contribute to molecular cancer diagnosis and prognosis.Keywords
This publication has 36 references indexed in Scilit:
- The ordering of expression among a few genes can provide simple cancer biomarkers and signal BRCA1 mutationsBMC Bioinformatics, 2009
- The tspair package for finding top scoring pair classifiers in RBioinformatics, 2009
- An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancerProceedings of the National Academy of Sciences, 2008
- Merging microarray data from separate breast cancer studies provides a robust prognostic testBMC Bioinformatics, 2008
- Protein subnetwork markers improve prediction of cancer outcomeMolecular Systems Biology, 2007
- Network‐based classification of breast cancer metastasisMolecular Systems Biology, 2007
- Large-scale integration of cancer microarray data identifies a robust common cancer signatureBMC Bioinformatics, 2007
- Highly accurate two-gene classifier for differentiating gastrointestinal stromal tumors and leiomyosarcomasProceedings of the National Academy of Sciences, 2007
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005
- Antiestrogen resistance in breast cancer and the role of estrogen receptor signalingOncogene, 2003